Quest Diagnostics

Quest Diagnostics Finds High Tick-Borne Disease Co-Exposure

Secaucus, New Jersey, U.S., September 21, 2026 Quest Diagnostics and researchers from the University of North Carolina at Chapel...

By cGxPwire Editor
September 23, 2026

MedTech

Quest Diagnostics Adds Roche pTau217 Blood Test to AD Portfolio

Secaucus, New Jersey, August 24, 2026 Quest Diagnostics announced new developments in its Quest AD-Detect® blood-testing portfolio, expanding access...

By cGxPwire Editor
August 25, 2026

MedTech

Quest Diagnostics Secures New York Approval for Haystack MRD Cancer Test

SECAUCUS, N.J., June 24, 2026 Quest Diagnostics announced that the New York State Department of Health’s Clinical Laboratory Evaluation...

By cGxPwire Editor
June 25, 2026

.Tech

Quest Launches AI Tool for Lab Result Insights

SECAUCUS, N.J., March 2, 2026 Quest Diagnostics (NYSE: DGX) has introduced Quest AI Companion, an AI-powered chat feature integrated...

By cGxPwire Editor
March 3, 2026

We work Hard to get you posted with latest updates

Unwrap our new Directory

Quest Diagnostics Finds High Tick-Borne Disease Co-Exposure

Quest Diagnostics Adds Roche pTau217 Blood Test to AD Portfolio

Quest Diagnostics Secures New York Approval for Haystack MRD Cancer Test

Quest Launches AI Tool for Lab Result Insights